Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 hepatic glycogen metabolism study in overweight or obese adults with type 2 diabetes
2017-005081-22Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cotadutide in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by AstraZeneca. Started Feb 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-005081-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005081-22.